ArticleIndian journal of urology : IJU : journal of the Urological Society of India
Efficacy and safety of programmed cell death-1/programmed cell death ligand-1 inhibitors in advanced urothelial malignancy: A systematic review and meta-analysis.
Smita Pattanaik et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.